Urology · West Bloomfield, MI
NPI
1376508762
Since 2006
Specialty
Urology
Code 208800000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
2300 Haggerty Rd, Suite 2000
West Bloomfield, MI, 48323
Phone (248) 624-9900
Groups this clinician bills Medicare through
Medicare paid, 2024
$469K
16,078 services
Medicare patients, 2024
1,251
Average age 75
Drug cost, 2024
$1.2M
5,099 prescriptions
Company payments, 2025
$2,125
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Gregory M Oldford was code J9030 (bcg live intravesical instillation, 1 mg), 2,350 times for 11 patients. In total Gregory M Oldford billed 16,078 services in 111 codes, and Medicare paid $469K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-01-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J9030 Bcg live intravesical instillation, 1 mg | Office | 2,350 | 11 | $2.19 | $5,139 |
| 81003 Clinical Chemistry | Office | 1,787 | 1,022 | $2.19 | $3,910 |
| 99214 Office E&M - Established | Office | 1,512 | 874 | $91.56 | $138K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,438 | 933 | $12.10 | $17K |
| 84153 Clinical Chemistry | Office | 723 | 555 | $18.00 | $13K |
| 80048 Clinical Chemistry | Office | 706 | 547 | $8.28 | $5,846 |
| 80076 Clinical Chemistry | Office | 702 | 542 | $8.00 | $5,616 |
| 99213 Office E&M - Established | Office | 385 | 282 | $63.66 | $25K |
| 76770 Ultrasound - Abdomen and Pelvis | Office | 343 | 182 | $35.86 | $12K |
| 51798 Ultrasound - Nonspecific | Office | 295 | 235 | $8.16 | $2,406 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 251 | 50 | $49.35 | $12K |
| J9217 Leuprolide acetate (for depot suspension), 7.5 mg | Office | 240 | 32 | $140.20 | $34K |
| 96372 Injection Administration | Office | 122 | 37 | $10.44 | $1,273 |
| 52000 Cystourethroscopy | Office | 119 | 104 | $184.25 | $22K |
| 99204 Office E&M - New | Office | 109 | 109 | $106.01 | $12K |
By year: 2022 $436K for 13,268 services; 2023 $425K for 12,741 services; 2024 $469K for 16,078 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 1,787 | 1,022 | $2.19 | $3,910 |
| 84153 Clinical Chemistry | 723 | 555 | $18.00 | $13K |
| 80048 Clinical Chemistry | 706 | 547 | $8.28 | $5,846 |
| 80076 Clinical Chemistry | 702 | 542 | $8.00 | $5,616 |
| 84403 Clinical Chemistry | 47 | 41 | $25.29 | $1,189 |
| 82670 Clinical Chemistry | 27 | 23 | $27.38 | $739 |
| 84154 Clinical Chemistry | 27 | 23 | $18.02 | $487 |
| 85025 Blood Count | 25 | 24 | $7.61 | $190 |
| 36415 Venipuncture Blood Collection | 19 | 19 | $8.65 | $164 |
| 84100 Clinical Chemistry | 16 | 15 | $4.65 | $74.4 |
Medicare prescription drug claims, 2024
In 2024, the drug Gregory M Oldford prescribed most often to Medicare patients was Tamsulosin Hcl, with 1,514 prescriptions and refills. In total Gregory M Oldford wrote 5,099 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 1,514 | 4,191 | 483 | $28K |
| Finasteride Generic | 958 | 2,706 | 294 | $18K |
| Gemtesa Vibegron | 398 | 792 | 115 | $359K |
| Methenamine Hippurate Generic | 351 | 867 | 104 | $25K |
| Myrbetriq Mirabegron | 337 | 808 | 127 | $346K |
| Alfuzosin Hcl Er Alfuzosin Hcl | 162 | 423 | 51 | $4,788 |
| Solifenacin Succinate Generic | 143 | 378 | 62 | $6,400 |
| Mirabegron Er Mirabegron | 125 | 315 | 55 | $78K |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 123 | 125 | 112 | $1,922 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 115 | 311 | 38 | $3,377 |
| Ciprofloxacin Hcl Generic | 106 | 106 | 96 | $492 |
| Dutasteride Generic | 105 | 259 | 26 | $5,070 |
| Silodosin Generic | 81 | 235 | 27 | $9,328 |
| Tolterodine Tartrate Er Tolterodine Tartrate | 62 | 166 | 21 | $7,584 |
| Potassium Citrate Er Potassium Citrate | 58 | 149 | 21 | $9,120 |
Brand drugs: - claims; generic drugs: 4,264 claims; opioid claims: 13.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Gregory M Oldford $2,125 ($2,125 in general payments such as food, travel and fees) from 24 companies. The largest payer was Sumitomo Pharma America, Inc. with $389.
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. 4506.T | 28 | $389 |
| Pfizer Inc. PFE | 10 | $178 |
| Teleflex LLC TFX | 1 | $161 |
| Merck Sharp & Dohme LLC MRK | 6 | $155 |
| Verity Pharmaceuticals Inc. | 5 | $113 |
| Olympus America Inc. | 4 | $108 |
| Abbvie Inc. ABBV | 5 | $106 |
| Dendreon Pharmaceuticals LLC | 4 | $105 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $100 |
| Antares Pharma, Inc. | 5 | $98.58 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.